SQIM

SQIM is a multidisciplinary, innovation-driven biotech and biomaterials company.

Total raised

€11M

€11,000,000

Funding rounds

Investors

distinct backers

Active since

2024-01

latest 2024-01

Funding by year

EUR raised per year

High confidence

Raise-next likelihood32

base rate 44% for Series A

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2024-01-09	Series A	€11M	CDP Venture Capital	View deal →

same sector or country